Venus Remedies Limited: AI-Driven GMP Compliance | Akshansh Chaudhary | AUTOMA+ 2025

Описание: Akshansh Chaudhary is Director and Chief Technology Officer at Venus Remedies Limited, an India-based pharmaceutical company specialising in injectable formulations, with a strong global footprint in antibiotics and oncology across more than one hundred markets.

At AUTOMA+ 2025, Akshansh presented Venus Remedies’ flagship initiative, Project Hyperlink — an AI-powered approach to GMP compliance. He explained how the company transformed regulatory readiness by digitally linking global regulations and guidelines directly to internal SOPs, making compliance traceable, provable, and instantly accessible during audits. His talk also reflected on broader conference themes such as legacy system digitisation, digital twins, and the emerging role of unconventional data sources in pharmaceutical operations and logistics.

He emphasised the value of AUTOMA+ as a space where pharma leaders can stay ahead of regulatory and digital trends, exchange insights with peers, and shape future-ready strategies. Akshansh also highlighted the role of BGS Group’s personal manager model in enabling tailored speaking opportunities, curated sessions, and highly relevant networking throughout the congress journey.

📍 Filmed at AUTOMA+ 2025 – Pharmaceutical Automation and Digitalisation Congress
🎥 Organised by BGS Group – https://bgs.group/

🔗 Learn more about AUTOMA+ – https://automa.plus/
🔗 Follow BGS Group for more insights –    / @bgsgroup  

#AUTOMAplus2025 #VenusRemedies #PharmaCompliance #GMP #AInPharma #DigitalTransformation #QualityManagement #RegulatoryTech #PharmaInnovation #BGSGroup

00:00 Introduction
00:44 Project Hyperlink
02:52 Conference insights
04:10 Personal manager support
05:39 Why AUTOMA+ matters